Quantcast

Latest MicroRNA Stories

2014-04-08 08:30:12

DUBLIN, April 8, 2014 /PRNewswire/ -- Dublin - Research and Markets ( http://www.researchandmarkets.com/research/tf3qn7/cancer_molecular) has announced the addition of the "Cancer Molecular Biomarkers 2014: A Global Market Study" [http://www.researchandmarkets.com/research/tf3qn7/cancer_molecular ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Technological advances in molecular biology over the last decade are accelerating...

2014-04-07 08:30:29

- Data Advances microRNA Oncology Portfolio - LA JOLLA, Calif., April 7, 2014 /PRNewswire/ -- Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that three abstracts will be presented in poster presentation sessions during the American Association for Cancer Research (AACR) Annual Meeting, which will be held April 5-9, 2014 in San Diego, CA. An oral presentation will also be...

2014-04-04 16:23:43

LA JOLLA, Calif., April 4, 2014 /PRNewswire/ -- Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that Neil W. Gibson, Ph.D., Chief Scientific Officer of Regulus, will present a company overview at the 13(th) Annual Needham Healthcare Conference on Wednesday, April 9, 2014 at 10:00 am EDT. The conference is being held at The Westin Grand Central Hotel in New York...

2014-03-31 13:31:39

Results of the study could help the 715,000 Americans who suffer from heart attacks each year Researchers at the Intermountain Medical Center Heart Institute in Salt Lake City have identified a biological process that may help physicians predict when someone with heart disease is likely to have a heart attack in the near future. A new study by the team has identified plasma levels of two markers – microRNA 122 and 126 – that appear to decline a few days before a person suffers a...

2014-03-25 08:29:32

LA JOLLA, Calif., March 25, 2014 /PRNewswire/ -- Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, and the Alport Syndrome Foundation ("ASF"), a non-profit corporation, announced today they are working together to raise awareness of Alport Syndrome, a life-threatening genetic kidney disease driven by genetic mutations with no approved therapy. This month, Regulus will join the...

Sea Anemone genetics
2014-03-18 13:58:44

Lee Rannals for redOrbit.com - Your Universe Online Researchers lead by evolutionary and developmental biologist Ulrich Technau at the University of Vienna say that a sea anemone has a genomic landscape that is half animal, half plant. Developmental biologists found that the genetic landscape of sea anemones features complex regulatory elements similar to that of fruit flies or other animal model systems. However, they also discovered that sea anemones are more similar to plants rather...

2014-03-18 08:30:09

LONDON, March 18, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:Global miRNA Market Outlook to 2018 The recent discovery of miRNA and its wide applicability have sparked off a lot of interest among researchers as well as commercial players. Owing to the same, there are numerous clinical trials being organized all over the world in order to assess the potential of miRNA in diverse fields such as Cancer, Asthma, Heart disorders, Diabetes, Hepatitis...

2014-03-05 08:28:56

- Study Designed to Demonstrate Human Proof-of-Concept Results by YE 2014 - LA JOLLA, Calif., March 5, 2014 /PRNewswire/ -- Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that it has commenced dosing RG-101, a GalNAc-conjugated anti-miR targeting microRNA-122 ("miR-122") in healthy volunteer subjects in a Phase I clinical study. The primary objective of the study...

2014-03-04 16:03:43

Researchers at New York University and the University of Texas at Austin have discovered that carbohydrates serve as identifiers for cancer cells. Their findings, which appear in the journal Proceedings of the National Academy of Sciences, show how these molecules may serve as signals for cancer and explain what's going on inside these cells, pointing to new ways in which sugars function as a looking glass into the workings of their underlying structures. "Carbohydrates can tell us a lot...

Fragile X Syndrome
2014-02-28 13:24:30

Brett Smith for redOrbit.com - Your Universe Online New research from a team of American researchers has found a genetic mechanism that shuts off the gene associated with fragile X syndrome – which causes developmental disorders such as mental retardation and autism. According to the team’s report in the journal Science, they were successfully able to a test drug that blocks this blocking mechanism. While it has been known that the syndrome is driven by the excessive repetition...


Word of the Day
sough
  • A murmuring sound; a rushing or whistling sound, like that of the wind; a deep sigh.
  • A gentle breeze; a waft; a breath.
  • Any rumor that engages general attention.
  • A cant or whining mode of speaking, especially in preaching or praying; the chant or recitative characteristic of the old Presbyterians in Scotland.
  • To make a rushing, whistling, or sighing sound; emit a hollow murmur; murmur or sigh like the wind.
  • To breathe in or as in sleep.
  • To utter in a whining or monotonous tone.
According to the OED, from the 16th century, this word is 'almost exclusively Scots and northern dialect until adopted in general literary use in the 19th.'
Related